The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis.
暂无分享,去创建一个
Z. Werb | Chieh Chang | Z Werb | C Chang | C. Chang
[1] F M Watt,et al. Out of Eden: stem cells and their niches. , 2000, Science.
[2] M. Moses,et al. A case of tumor betrayal: biphasic effects of TIMP-1 on Burkitt's lymphoma. , 2001, The American journal of pathology.
[3] Z. Werb,et al. Matrix Metalloproteinase-9/Gelatinase B Is Required for Process Outgrowth by Oligodendrocytes , 1999, The Journal of Neuroscience.
[4] G. Bergers,et al. Matrix metalloproteinases as emerging targets in anticancer therapy: status and prospects , 2000 .
[5] I. Stamenkovic,et al. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. , 2000, Genes & development.
[6] M J Bissell,et al. Tumors are unique organs defined by abnormal signaling and context. , 2001, Seminars in cancer biology.
[7] Thiennu H. Vu,et al. Matrix metalloproteinases: effectors of development and normal physiology. , 2000, Genes & development.
[8] C. Heldin,et al. PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor , 2001, Nature Cell Biology.
[9] Z. Werb. ECM and Cell Surface Proteolysis: Regulating Cellular Ecology , 1997, Cell.
[10] Y. Ma,et al. Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[11] M. Detmar,et al. Thrombospondin‐2 plays a protective role in multistep carcinogenesis: a novel host anti‐tumor defense mechanism , 2001, The EMBO journal.
[12] A. Krüger,et al. Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis. , 2001, Cancer research.
[13] G. Christofori,et al. Fibroblast growth factors are required for efficient tumor angiogenesis. , 2000, Cancer research.
[14] Thiennu H. Vu,et al. Don't mess with the matrix , 2001, Nature Genetics.
[15] Z. Werb,et al. How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.
[16] A. Pozzi,et al. Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[17] M. Tessier-Lavigne,et al. Function of an axonal chemoattractant modulated by metalloprotease activity. , 2000, Science.
[18] J. Sun,et al. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. , 2001, Cancer research.
[19] J. Rothberg,et al. PDGF-D, a new protease-activated growth factor , 2001, Nature Cell Biology.
[20] L. Coussens,et al. Inflammatory Cells and Cancer , 2001, The Journal of experimental medicine.
[21] P. Carmeliet,et al. Angiogenesis in cancer and other diseases , 2000, Nature.
[22] P. Sternberg,et al. Working in the Post-Genomic C. elegans World , 2001, Cell.
[23] A. Gaultier,et al. Xenopus ADAM 13 is a metalloprotease required for cranial neural crest-cell migration , 2001, Current Biology.
[24] Shigeyoshi Itohara,et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.
[25] D. Bredesen,et al. The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[26] I. Vlodavsky,et al. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. , 2001, The Journal of clinical investigation.
[27] L. Matrisian,et al. Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesis , 1998, International journal of cancer.
[28] T. Mcclanahan,et al. Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.
[29] Fiona M Watt,et al. c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny , 2001, Current Biology.
[30] P. Bornstein,et al. Matricellular proteins as modulators of cell-matrix interactions: adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2. , 2000, Molecular biology of the cell.
[31] M. Humphries,et al. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. , 1986, Science.
[32] J G Flanagan,et al. Regulated cleavage of a contact-mediated axon repellent. , 2000, Science.
[33] W. Stetler-Stevenson,et al. Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis. , 2001, The American journal of pathology.
[34] L. Devy,et al. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis. , 2001, Cancer research.
[35] T. Ferguson,et al. Neuronal Matrix Metalloproteinase-2 Degrades and Inactivates a Neurite-Inhibiting Chondroitin Sulfate Proteoglycan , 1998, The Journal of Neuroscience.
[36] Yihai Cao,et al. Proteolytic processing regulates receptor specificity and activity of VEGF‐C , 1997, The EMBO journal.
[37] N. Seeds,et al. Plasminogen activator release at the neuronal growth cone. , 1981, Science.
[38] P. Primakoff,et al. The ADAM gene family: surface proteins with adhesion and protease activity. , 2000, Trends in genetics : TIG.
[39] G. Giannelli,et al. Role of Cell Surface Metalloprotease Mt1-Mmp in Epithelial Cell Migration over Laminin-5 , 2000, The Journal of cell biology.
[40] E. Pasquale,et al. Eph receptors and ephrin ligands: embryogenesis to tumorigenesis , 2000, Oncogene.
[41] R. Jaenisch,et al. Targeted mutagenesis of Timp-1 reveals that lung tumor invasion is influenced by Timp-1 genotype of the tumor but not by that of the host. , 1996, Oncogene.
[42] G. Garcı́a-Cardeña,et al. Oligomerization-Dependent Regulation of Motility and Morphogenesis by the Collagen Xviii Nc1/Endostatin Domain , 2001, The Journal of cell biology.
[43] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[44] Eric S. Lander,et al. Genomic analysis of metastasis reveals an essential role for RhoC , 2000, Nature.